Page 37 - GHES-3-3

Global Health Economics and
Sustainability
Semaglutide for treating T2D and obesity

Writing–review & editing: All authors Angelis, A., Lange, A., & Kanavos, P. (2018). Using health
technology assessment to assess the value of new medicines:
Ethics approval and consent to participate Results of a systematic review and expert consultation across
eight European countries. The European Journal of Health
Not applicable.
Economics, 19(1):123-152.
Consent for publication https://doi.org/10.1007/s10198-017-0871-0
Not applicable. Benney, T., & Cohen, B. (2022). The international currency system
revisited. Review of Keynesian Economics, 10(4):443-461.
Availability of data Chantzaras, A.E., & Yfantopoulos, J.N. (2018). Financial
Not applicable. protection of households against health shocks in Greece
during the economic crisis. Social Science and Medicine,
References 211:338-351.
Aldawsari, M., Almadani, F.A., Almuhammadi, N., Algabsani, S., https://doi.org/10.1016/j.socscimed.2018.06.024
Alamro, Y., & Aldhwayan, M. (2023). The efficacy of GLP-1 Choi, J.G., Winn, A.N., Skandari, M.R., Franco, M.I., Staab,
analogues on appetite parameters, gastric emptying, food E.M., Alexander, J., et al. (2022). First-line therapy for
preference and taste among adults with obesity: Systematic type 2 diabetes with sodium-glucose cotransporter-2
review of randomized controlled trials. Diabetes, Metabolic inhibitors and glucagon-like peptide-1 receptor agonists:
Syndrome and Obesity, 16:575-595. A cost-effectiveness study. Annals of Internal Medicine,
https://doi.org/10.2147/DMSO.S387116 175(10):1392-1400.
Alkhatib, N.S., Almutairi, A.R., Alkhezi, O.S., Alfayez, O.M., https://doi.org/10.7326/M21-2941
Al Yami, M.S., & Almohammed, O.A. (2022). Economic Ciardullo, S., Savare, L., Rea, F., Perseghin, G., & Corrao, G.
analysis of glucagon like peptide-1 receptor agonists from (2024). Adherence to GLP1-RA and SGLT2-I affects
the Saudi Arabia payer perspective. Saudi Pharmaceutical clinical outcomes and costs in patients with type 2 diabetes.
Journal, 30(4):433-439. Diabetes/Metabolism Research and Reviews, 40(4):e3791.
https://doi.org/10.1016/j.jsps.2022.01.018 https://doi.org/10.1002/dmrr.3791
Alqahtani, S.A., Al-Omar, H.A., Alshehri, A., Abanumay, A., D’Andrea, E., Wexler, D.J., Kim, S.C., Paik, J.M., Alt, E., &
Alabdulkarim, H., Alrumaih, A., et al. (2023). Obesity Patorno, E. (2023). Comparing effectiveness and safety of
burden and impact of weight loss in Saudi Arabia: SGLT2 inhibitors vs DPP-4 inhibitors in patients with type 2
A modelling study. Advances in Therapy, 40(3):1114-1128. diabetes and varying baseline HbA1c levels. JAMA Internal
https://doi.org/10.1007/s12325-022-02415-8 Medicine, 183(3):242-254.
Al-Sabah, S., ElShamy, A., Jois, S., Low, K., Gras, A., & Gulnar, E.P. https://doi.org/10.1001/jamainternmed.2022.6664
(2023). The economic impact of obesity in Kuwait: A micro- De Bromhead, A., Jordan, D., Kennedy, F., & Seddon, J. (2023).
costing study evaluating the burden of obesity-related Sterling’s farewell symphony: The end of the Sterling Area
comorbidities. Journal of Medical Economics, 26(1):1368-1376. revisited. The Economic History Review, 76(2):415-444.
https://doi.org/10.1080/13696998.2023.2265721 https://doi.org/10.1111/ehr.13175
American Diabetes Association Professional Practice Committee. Durden, E., Liang, M., Fowler, R., Panton, U.H., & Mocevic, E.
(2025a). 2. Diagnosis and classification of diabetes: Standards (2019). The effect of early response to GLP-1 RA therapy on
of care in diabetes-2025. Diabetes Care, 48(Suppl 1):S27-S49.
long-term adherence and persistence among type 2 diabetes
https://doi.org/10.2337/dc25-S002 patients in the United States. Journal of Managed Care and
Specialty Pharmacy, 25(6):669-680.
American Diabetes Association Professional Practice Committee.
(2025b). 8. Obesity and weight management for the https://doi.org/10.18553/jmcp.2019.18429
prevention and treatment of type 2 diabetes: Standards of Evans, M., Engberg, S., Faurby, M., Fernandes, J., Hudson, P.,
care in diabetes-2025. Diabetes Care, 48(Suppl 1):S167-S180.
& Polonsky, W. (2022). Adherence to and persistence with
https://doi.org/10.2337/dc25-S008 antidiabetic medications and associations with clinical
and economic outcomes in people with type 2 diabetes
Anam, M., Maharjan, S., Amjad, Z., Abaza, A., Vasavada, A.M.,
Sadhu, A., et al. (2022). Efficacy of semaglutide in treating mellitus: A systematic literature review. Diabetes, Obesity
and Metabolism, 24(3):377-390.
obesity: A systematic review of randomized controlled trials
(RCTs). Cureus, 14(12):e32610. https://doi.org/10.1111/dom.14603
https://doi.org/10.7759/cureus.32610 Filippatos, T.D., Panagiotopoulou, T.V., & Elisaf, M.S. (2014).

Volume 3 Issue 3 (2025) 29 https://doi.org/10.36922/ghes.8547